<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE301nnn/GSE301567/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301567</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Effect of MEK inhibiton on KrasQ61R mutant Lgr5-positive intestinal stem cells</name><description>We have previously shown that KRAS hyperactivation depletes the Lgr5-positive intestinal stem cells. Here, we aim to address whether reducing the MAPK pathway output, by using a MEK inhibitor (Cobimetinib) is sufficient to restore expression of Lgr5-positive intestinal stem cell markers.</description><dates><publication>2026/04/05</publication></dates><accession>GSE301567</accession><cross_references><GSM>GSM9085445</GSM><GSM>GSM9085440</GSM><GSM>GSM9085443</GSM><GSM>GSM9085444</GSM><GSM>GSM9085441</GSM><GSM>GSM9085442</GSM><GPL>15103</GPL><GSE>301567</GSE><taxon>Mus musculus</taxon></cross_references></HashMap>